Fumiko Uesugi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections.

Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections.

Journal: Respiratory medicine

Published: January 31, 2024

Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.

Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.

Journal: Respiratory medicine

Published: April 25, 2023

Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB.

Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB.

Journal: Chest

Published: January 19, 2023

Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan.

Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan.

Journal: ERJ open research

Published: August 22, 2022

Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.

Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.

Journal: Antimicrobial agents and chemotherapy

Published: July 21, 2022

Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.

Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.

Journal: Microbiology spectrum

Published: December 08, 2021

Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.

Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.

Journal: Infection

Published: September 08, 2021

Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patients.

Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patients.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 28, 2020

Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease.

Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: June 25, 2020

Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease.

Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: June 06, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026